Development of PolyHis‐Targeting PROTAC Degraders

H Hui Chen D Dong Zhu M Monica Billitti (Georgia Cancer Center Augusta University Augusta Georgia USA) A Annan Sun (Department of Medicinal Chemistry College of Pharmacy University of Florida Gainesville Florida USA) L Lingtao Jin (Department of Molecular Medicine University of Texas Health San Antonio San Antonio Texas USA) E Emily Moser (Department of Pulmonary Critical Care and Sleep Medicine College of Medicine University of Florida Gainesville Florida USA) N Nahid F. Mivechi (Georgia Cancer Center Augusta University Augusta Georgia USA) G Guangrong Zheng D Dongwen Lv (Georgia Cancer Center Augusta University Augusta Georgia USA)

Abstract

ABSTRACT Targeted protein degradation (TPD) via proteolysis targeting chimeras (PROTACs) enables selective removal of proteins of interest (POIs) by hijacking the ubiquitin‐proteasome system (UPS). However, broad application is constrained by the availability of high‐quality target ligands, which remain scarce for much of the human proteome, limiting assessment of POIs for UPS‐mediated degradation. To address this challenge, we developed polyhistidine‐targeting PROTACs (polyHisTACs) by conjugating a nickel‐nitrilotriacetic acid (Ni 2 + ‐NTA) headgroup to ligands of VHL or CRBN, thereby recruiting these E3 ligase complexes to polyHis‐tagged POIs. As expected, polyHisTACs effectively degraded CRISPR‐engineered, endogenously polyHis‐tagged BRD4 and also induced robust degradation of an exogenously expressed polyHis‐tagged RNA‐binding protein, PSPC1, a target that is typically considered undruggable. In summary, polyHisTACs overcome key limitations of existing tag‐based degrader systems by leveraging a minimal, easily implemented polyHis tag. This platform provides a versatile, reliable way to evaluate UPS‐mediated degradability in the absence of target‐specific ligands and serves as a practical tool for acute POI depletion in basic research.

Article Details

Volume / Issue Vol. 65, Issue 11
Published March 09, 2026
ISSN 1433-7851
Publisher Wiley

Journal Info

Angewandte Chemie International Edition

Wiley

ISSN: 1433-7851 Physical Sciences

Authors (9)

H

Hui Chen

D

Dong Zhu

M

Monica Billitti

Georgia Cancer Center Augusta University Augusta Georgia USA

A

Annan Sun

Department of Medicinal Chemistry College of Pharmacy University of Florida Gainesville Florida USA

L

Lingtao Jin

Department of Molecular Medicine University of Texas Health San Antonio San Antonio Texas USA

E

Emily Moser

Department of Pulmonary Critical Care and Sleep Medicine College of Medicine University of Florida Gainesville Florida USA

N

Nahid F. Mivechi

Georgia Cancer Center Augusta University Augusta Georgia USA

G

Guangrong Zheng

D

Dongwen Lv

Georgia Cancer Center Augusta University Augusta Georgia USA